@article{f0b2164af50f42db8d2ef54077f0fd41,
title = "Clinical characteristics of women captured by extending the definition of severe postpartum haemorrhage with 'refractoriness to treatment': A cohort study",
abstract = "Background: The absence of a uniform and clinically relevant definition of severe postpartum haemorrhage hampers comparative studies and optimization of clinical management. The concept of persistent postpartum haemorrhage, based on refractoriness to initial first-line treatment, was proposed as an alternative to common definitions that are either based on estimations of blood loss or transfused units of packed red blood cells (RBC). We compared characteristics and outcomes of women with severe postpartum haemorrhage captured by these three types of definitions. Methods: In this large retrospective cohort study in 61 hospitals in the Netherlands we included 1391 consecutive women with postpartum haemorrhage who received either ≥4 units of RBC or a multicomponent transfusion. Clinical characteristics and outcomes of women with severe postpartum haemorrhage defined as persistent postpartum haemorrhage were compared to definitions based on estimated blood loss or transfused units of RBC within 24 h following birth. Adverse maternal outcome was a composite of maternal mortality, hysterectomy, arterial embolisation and intensive care unit admission. Results: One thousand two hundred sixty out of 1391 women (90.6%) with postpartum haemorrhage fulfilled the definition of persistent postpartum haemorrhage. The majority, 820/1260 (65.1%), fulfilled this definition within 1 h following birth, compared to 819/1391 (58.7%) applying the definition of ≥1 L blood loss and 37/845 (4.4%) applying the definition of ≥4 units of RBC. The definition persistent postpartum haemorrhage captured 430/471 adverse maternal outcomes (91.3%), compared to 471/471 (100%) for ≥1 L blood loss and 383/471 (81.3%) for ≥4 units of RBC. Persistent postpartum haemorrhage did not capture all adverse outcomes because of missing data on timing of initial, first-line treatment. Conclusion: The definition persistent postpartum haemorrhage identified women with severe postpartum haemorrhage at an early stage of haemorrhage, unlike definitions based on blood transfusion. It also captured a large majority of adverse maternal outcomes, almost as large as the definition of ≥1 L blood loss, which is commonly applied as a definition of postpartum haemorrhage rather than severe haemorrhage.",
keywords = "Definition, Maternal morbidity, Maternal mortality, Postpartum haemorrhage",
author = "Henriquez, {Dacia D.C.A.} and Ada Gillissen and Smith, {Sharissa M.} and Cramer, {Roos A.} and {Van Den Akker}, Thomas and Zwart, {Joost J.} and {Van Roosmalen}, {Jos J.M.} and Bloemenkamp, {Kitty W.M.} and {Van Der Bom}, {Johanna G.} and Adriaanse, {H. J.} and {Van Den Akker}, {E. S.A.} and Baas, {M. I.} and Bank, {C. M.C.} and {Van Beek}, E. and {De Boer}, {B. A.} and {De Boer}, K. and {Van Der Borden}, {D. M.R.} and Bremer, {H. A.} and Brons, {J. T.J.} and Burggraaff, {J. M.} and H. Ceelie and H. Chon and Cikot, {J. L.M.} and Delemarre, {F. M.C.} and Diris, {J. H.C.} and Kleffens, {M. Doesburg Van} and {Van Dooren}, {I. M.A.} and {Van Duijnhoven}, {J. L.P.} and {Van Dunn{\'e}}, {F. M.} and Duvekot, {J. J.} and P. Engbers and Hulst, {M. J.W.Van Etten Van} and H. Feitsma and Fouraux, {M. A.} and Franssen, {M. T.M.} and Frasa, {M. A.M.} and {Van Gammeren}, {A. J.} and {Van Gemund}, N. and {Van Der Graaf}, F. and {De Groot}, {C. J.M.} and Hackeng, {C. M.} and {Van Der Ham}, {D. P.} and Hanssen, {M. J.C.P.} and Hasaart, {T. H.M.} and Hendriks, {H. A.} and Henskens, {Y. M.C.} and Hermsen, {B. B.J.} and S. Hogenboom and A. Hooker and F. Hudig and Huijssoon, {A. M.G.} and Huisjes, {A. J.M.} and N. Jonker and Kabel, {P. J.} and {Van Kampen}, C. and {De Keijzer}, {M. H.} and {Van De Kerkhof}, {D. H.} and Keuren, {J. F.W.} and G. Kleiverda and Klinkspoor, {J. H.} and Koehorst, {S. G.A.} and M. Kok and Kok, {R. D.} and {De Kok}, {J. B.} and A. Koops and W. Kortlandt and J. Langenveld and Leers, {M. P.G.} and A. Leyte and {De Mare}, A. and Martens, {G. D.M.} and Meekers, {J. H.} and {Van Meir}, {C. A.} and Metz, {G. C.H.} and Michielse, {E. C.H.J.} and Mostert, {L. J.} and Bijvank, {S. W.H.Nij} and E. Oostenveld and N. Osmanovic and Oudijk, {M. A.} and {Pagano Mirani-Oostdijk}, C. and {Van Pampus}, {E. C.M.} and Papatsonis, {D. N.M.} and Peters, {R. H.M.} and Ponjee, {G. A.E.} and M. Pontesilli and Porath, {M. M.} and Post, {M. S.} and Pouwels, {J. G.J.} and L. Prinzen and Roelofsen, {J. M.T.} and Rondeel, {J. J.M.} and {Van Der Salm}, {P. C.M.} and Scheepers, {H. C.J.} and Schippers, {D. H.} and Schuitemaker, {N. W.E.} and Sikkema, {J. M.} and J. Slomp and Smit, {J. W.} and Lange, {Y. S.Snuif De} and {Van Der Stappen}, {J. W.J.} and P. Steures and Tax, {G. H.M.} and M. Treskes and Ulenkate, {H. J.L.M.} and {Van Unnik}, {G. A.} and {Van Der Veen}, {B. S.} and Verhagen, {T. E.M.} and J. Versendaal and B. Visschers and O. Visser and H. Visser and {De Vooght}, {K. M.K.} and {De Vries}, {M. J.} and {De Waard}, H. and F. Weerkamp and Weinans, {M. J.N.} and {De Wet}, H. and {Van Wijnen}, M. and {Van Wijngaarden}, {W. J.} and {De Wit}, {A. C.} and Woiski, {M. D.} and {TeMpOH-1 Study Group}",
year = "2019",
month = oct,
day = "17",
doi = "10.1186/s12884-019-2499-9",
language = "English",
volume = "19",
pages = "1--10",
journal = "BMC Pregnancy and Childbirth",
issn = "1471-2393",
publisher = "BioMed Central Ltd.",
}